Being active may improve radiation therapy outcomes
Patients who are physically active before they undergo thoracic radiation therapy...Read more on AuntMinnie.comRelated Reading: ASTRO, ACR update RT practice parameters RT improves elderly brain cancer patient survival IMV: Imaging boosts precision in radiation therapy ASTRO: Whole, partial breast RT yield similar cosmetic results Varian to highlight RT management system at AAPM meeting (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 14, 2020 Category: Radiology Source Type: news

Thoracic Radiation May Increase Fatigue, Dyspnea in Short Term
FRIDAY, Feb. 14, 2020 -- Thoracic radiation therapy (RT) is associated with increased fatigue and dyspnea as well as decreased physical activity, according to a study presented at the Cardiovascular Care of the Oncology Patient conference organized... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 14, 2020 Category: Pharmaceuticals Source Type: news

Radiation therapy to heart can worsen fatigue, shortness of breath in cancer patients
(American College of Cardiology) Radiation doses to the heart that occur during radiation therapy treatments for lung cancer, breast cancer and lymphoma can increase fatigue, cause difficulty breathing and lower capacity for physical activity in patients with cancer, according to research presented at the American College of Cardiology's Advancing the Cardiovascular Care of the Oncology Patient course. The course examines new science and best practices in assessing, diagnosing and treating the unique cardiovascular concerns of patients with cancer and/or those requiring survivorship care. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 14, 2020 Category: International Medicine & Public Health Source Type: news

Much shorter radiation treatment found to be safe, effective for people with soft tissue sarcoma
In this study at UCLA, a national leader in the care of patients with sarcoma, researchers used a condensed five-day radiation regimen that considerably cuts down the length of treatment and the time to surgery.“Shortening the radiation therapy from five weeks to five days has been a very meaningful change for patients,” said lead author Dr. Anusha Kalbasi, assistant professor of radiation oncology in the division of molecular and cellular oncology. “Five weeks of daily treatments is a burdensome com mitment for patients. The daily back-and-forth can be expensive and time consuming, and it can really inte...
Source: UCLA Newsroom: Health Sciences - February 13, 2020 Category: Universities & Medical Training Source Type: news

MIM Software, Sitex team up to treat cancer
Medical imaging software developer MIM Software will collaborate with radiation...Read more on AuntMinnie.comRelated Reading: IsoRay, MIM Software team on treatment for head, neck cancer Sirtex names new CEO MIM Software adds to customer list Philips, MIM to collaborate on radiation therapy Varian's Sirtex purchase falls through Varian tells Sirtex it won't submit counterproposal (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 12, 2020 Category: Radiology Source Type: news

iCAD reports Xoft Axxent milestone
Computer-aided detection (CAD) software developer iCAD said that its Xoft Axxent...Read more on AuntMinnie.comRelated Reading: iCAD features AI software for breast imaging at RSNA iCAD features Xoft Axxent upgrades at ASTRO 2019 iCAD to highlight AI for tomosynthesis at ECR iCAD touts clinical results with Xoft Axxent brachytherapy iCAD touts study on radiation therapy savings (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 12, 2020 Category: Radiology Source Type: news

Varian gets FDA nod for Ethos adaptive therapy unit
Radiation therapy firm Varian Medical Systems has garnered U.S. Food and Drug...Read more on AuntMinnie.comRelated Reading: Varian posts strong Q1 sales growth as profit slips Varian installs systems in Africa, U.S. Varian awarded Mich. cancer software contract Varian posts continued revenue gains in Q4, fiscal 2019 Varian taps power of AI for Ethos adaptive therapy unit (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 11, 2020 Category: Radiology Source Type: news

Akesis gets FDA clearance for radiosurgery system
Radiation therapy developer Akesis has received 510(k) clearance from the U.S....Read more on AuntMinnie.comRelated Reading: Akesis launches new rad therapy systems at ASTRO 2019 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 7, 2020 Category: Radiology Source Type: news

Accuray touts 2 radiation therapy studies
Radiation oncology firm Accuray is touting results from two studies that investigate...Read more on AuntMinnie.comRelated Reading: Accuray posts mixed Q2 results Accuray touts CyberKnife study results Accuray makes 1st Radixact install in Utah Accuray, RaySearch treat 1st patients in Asia-Pacific Accuray appoints former GE manager as CCO (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 6, 2020 Category: Radiology Source Type: news

IsoRay, MIM Software team on treatment for head, neck cancer
Medical isotope developer IsoRay will collaborate with medical imaging software...Read more on AuntMinnie.comRelated Reading: MIM Software adds to customer list Philips, MIM to collaborate on radiation therapy IsoRay's cesium-131 brachytherapy aids prostate surgery MIM nets FDA OK for dosimetry software IsoRay's GammaTile therapy receives FDA OK IsoRay revenues climb in Q4 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 5, 2020 Category: Radiology Source Type: news

Janssen to Highlight Depth of Solid Tumor Portfolio at ASCO GU
RARITAN, N.J., February 3, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple data presentations from a robust solid tumor portfolio that will be featured at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15 in San Francisco. Company-sponsored data presentations will include clinical results for ERLEADA® (apalutamide) and niraparib in prostate cancer; and BALVERSA™ (erdafitinib) in bladder cancer. “We are committed to improving outcomes in patients with prostate and bladder cancer where high unmet...
Source: Johnson and Johnson - February 3, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Reirradiation Rarely Required in Focal RT for Multiple Myeloma
FRIDAY, Jan. 31, 2020 -- For patients with multiple myeloma receiving focal radiation therapy (RT) for symptomatic plasmacytoma, reirradiation is rarely required, according to a letter to the editor published online Jan. 9 in Haematologica. Adnan... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 31, 2020 Category: Pharmaceuticals Source Type: news

Researchers Capture First Images of Oxygen in Cancer Tumors During Radiation Therapy
Using specialty cameras and an oxygen probe drug injection, researchers at Dartmouth's Norris Cotton Cancer Center can now image oxygen from within cancer tumors during radiation while the probe is excited by Cherenkov light, a byproduct of radiation. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - January 30, 2020 Category: Hospital Management Authors: NonPerson Geisel Web Service Acct Tags: News Press Release cancer Norris Cotton Cancer Center research Source Type: news

Varian posts strong Q1 sales growth as profit slips
Radiation therapy firm Varian Medical Systems reported 13% growth in revenues...Read more on AuntMinnie.comRelated Reading: Varian installs systems in Africa, U.S. Varian awarded Mich. cancer software contract Varian posts continued revenue gains in Q4, fiscal 2019 Varian inks software development deal with MD Anderson Varian reports Flash therapy milestone (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 30, 2020 Category: Radiology Source Type: news

Researchers Capture First Images of Oxygen in Cancer Tumors during Radiation Therapy
Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be an important factor in resistance to therapy. However, it is difficult to monitor tumor oxygenation without invasive sampling of oxygen distributions throughout the tissue, or without averaging across the whole tumor, whereas oxygen is highly heterogenous within a tumor. (Source: eHealth News EU)
Source: eHealth News EU - January 29, 2020 Category: Information Technology Tags: Featured Events Source Type: news

Researchers capture first images of oxygen in cancer tumors during radiation therapy
(Dartmouth-Hitchcock Medical Center) Oxygen in cancer tumors is a known major factor in the success of radiation therapy, but currently there are no good ways to monitor tumor oxygenation during this treatment. With specialty cameras and injection of an oxygen probe drug, researchers at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center have demonstrated the first way to directly monitor the full range of oxygen distributions within the tumor right at the time when radiation therapy is happening. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 29, 2020 Category: Cancer & Oncology Source Type: news

AI can jump-start radiation therapy for cancer patients
(UT Southwestern Medical Center) Artificial intelligence can help cancer patients start their radiation therapy sooner -- and thereby decrease the odds of the cancer spreading -- by instantly translating complex clinical data into an optimal plan of attack. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 27, 2020 Category: International Medicine & Public Health Source Type: news

Intensity-Modulated Radiation Charges for Prostate Cancer Vary
TUESDAY, Jan. 21, 2020 -- There is considerable variation in listed charges for simple intensity-modulated radiation therapy used in prostate cancer treatment, with a weak positive association for price and geographic practice cost index, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 21, 2020 Category: Pharmaceuticals Source Type: news

IMV: MR providers work harder as procedure volume grows
If you feel like you're working harder just to keep up, you're not mistaken....Read more on AuntMinnie.comRelated Reading: IMV: Global radiologists are optimistic despite local challenges IMV: Imaging boosts precision in radiation therapy IMV: Fixed C-arms improve interventional outcomes IMV: PET/CT drives PET scan volume to new heights IMV: DR now makes up 80% of radiography installed base (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 15, 2020 Category: Radiology Source Type: news

ViewRay expects revenue growth in 2019, despite slow Q4
Image-guided radiation therapy vendor ViewRay reported in its preliminary results...Read more on AuntMinnie.comRelated Reading: ViewRay inks deal with Elekta, Medtronic ViewRay subject to class-action lawsuits ViewRay inks MRIdian order from Penn State Health ViewRay wins Stanford contract ViewRay highlights presentations at ASTRO 2019 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 14, 2020 Category: Radiology Source Type: news

Study suggests biological clock is key to reducing heart damage from radiation therapy
(Washington State University) A new study suggests that the biological clock is involved in heart toxicity from radiation therapy and could be harnessed as part of a preventive strategy. Findings show that after receiving radiation to the heart, mice with disrupted biological clocks had significantly worse heart function than controls. They also demonstrated that Bmal1--a protein that drives 24-hour rhythms in the expression of many genes--plays an important role in protecting the heart from radiation-related damage. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 13, 2020 Category: International Medicine & Public Health Source Type: news

Researchers find fast way to deliver radiation therapy to cancer patients
Researchers at the Abramson Cancer Center of the University of Pennsylvania may have found a safe and effective way to deliver an entire course of radiation therapy in less than a second, using FLASH radiotherapy. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 9, 2020 Category: Consumer Health News Source Type: news

Radiation treatment for cancer could be done a single one SECOND
Scientists at the Pennsylvania University developed 'FLASH' radiation therapy, which they say will deliver a full course of treatment's worth of radiation in a single one-second dose via protons. (Source: the Mail online | Health)
Source: the Mail online | Health - January 9, 2020 Category: Consumer Health News Source Type: news

Penn shows giving entire course of radiation treatment in less than a second is feasible
(University of Pennsylvania School of Medicine) Cancer patients may one day be able to get their entire course of radiation therapy in less than a second rather than coming in for treatment over the course of several weeks, and researchers in the Abramson Cancer Center of the University of Pennsylvania have taken the first steps toward making it a reality. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 9, 2020 Category: Cancer & Oncology Source Type: news

New study suggests 21-gene recurrence score may help in radiation decision-making
(SWOG) A new study shows that a test physicians commonly used to guide chemotherapy treatment for post-breast cancer surgery patients may also help them decide whether radiation therapy may be of benefit. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 9, 2020 Category: Cancer & Oncology Source Type: news

Nanobiotix plans head and neck cancer treatment trial
Nanotech radiation therapy technology developer Nanobiotix said it will launch...Read more on AuntMinnie.com (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 8, 2020 Category: Radiology Source Type: news

Tanzania: Bmh Starts Radiation Therapy for Cancer Patients
[Daily News] BENJAMIN Mkapa Hospital (BMH) through its Oncology Unit plans to begin offering radiation therapy as a cancer treatment method that controls or kills the disease's malignant cells. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 3, 2020 Category: African Health Source Type: news

Feinstein Institute gets FDA approval for PET Parkinson's agent
The U.S. Food and Drug Administration (FDA) has granted approval to the Feinstein...Read more on AuntMinnie.comRelated Reading: Augmedics gets FDA clearance for AR-guided surgery system Bayer gets FDA nod for contrast with mammography Elekta gets FDA nod for DWI-MR radiation therapy DWI-MRI shows vision changes could predict Parkinson's DTI-MRI sheds light on Parkinson's disease (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 3, 2020 Category: Radiology Source Type: news

Using a systems-theoretic approach to analyze safety in radiation therapy-first steps and lessons learned - Silvis-Cividjian N, Verbakel W, Admiraal M.
Radiation therapy is an important technique to treat cancer. Due to the high occupational risks involved, the process is subject to severe safety regulations and standards. However, these standards do not mandate the usage of a particular hazard analysis m... (Source: SafetyLit)
Source: SafetyLit - January 2, 2020 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

ASTRO Releases Clinical Guideline for Radiation Therapy in Treating Patients with Skin Cancer
The recommendations defined when and how radiation therapy should be used to treat patients with basal cell carcinoma and cutaneous squamous cell carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - December 31, 2019 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Acupuncture May Ease a Common Side Effect of Cancer Treatment, Dry Mouth
FRIDAY, Dec. 27, 2019 -- Dry mouth can be a troubling side effect of radiation therapy, but acupuncture may ease its symptoms, a new study suggests. Of 339 patients getting radiation for head and neck cancer in the United States and China, those... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 27, 2019 Category: General Medicine Source Type: news

Proton therapy as effective as standard radiation with fewer side effects
(Washington University School of Medicine) Cancer patients who receive high-tech proton therapy experience similar cure rates and fewer serious side effects compared with those who undergo traditional X-ray radiation therapy, according to a study led by Washington University School of Medicine in St. Louis and the Perelman School of Medicine at the University of Pennsylvania. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 27, 2019 Category: Cancer & Oncology Source Type: news

ASTRO Issues Recs for Radiation Tx of Basal, Squamous Cell Carcinoma
TUESDAY, Dec. 24, 2019 -- In an executive summary of an American Society for Radiation Oncology clinical practice guideline, published online Dec. 9 in Practical Radiation Oncology, recommendations are presented for the use of radiation therapy (RT)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 24, 2019 Category: Pharmaceuticals Source Type: news

Clinical Guideline Released for Radiation Therapy in Treating Patients with Skin Cancer
Recommendations defined when and how radiation therapy should be used to treat patients with basal cell carcinoma and cutaneous squamous cell carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - December 20, 2019 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Michigan Community Hospital Begins Patient Treatments with ViewRay's MRIdian Linac
Sparrow Health System Now Delivering On-Table Adaptive Therapy with New MRI-Guided Radiation Therapy System CLEVELAND, Dec. 19, 2019 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Sparrow Health System in... Devices, Oncology ViewRay, MRIdian, MRI-guided radiation therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 19, 2019 Category: Pharmaceuticals Source Type: news

Elekta gets FDA nod for DWI-MR radiation therapy
Radiation oncology vendor Elekta has received 510(k) premarket notification...Read more on AuntMinnie.comRelated Reading: ViewRay inks deal with Elekta, Medtronic Elekta secures 5-year Premier contract Elekta, DOSIsoft sign distribution agreement Elekta gets another Canadian nod for Unity Elekta appoints new president of oncology informatics (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 16, 2019 Category: Radiology Source Type: news

Medical News Today: Cancer: Common antibiotic may boost immune system
New research in mice suggests that administering a common antibiotic before radiation therapy can help the immune system fight off cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 11, 2019 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

PET rules out need for radiotherapy in lymphoma patients
Most patients with diffuse large B-cell lymphoma who have a clear PET scan...Read more on AuntMinnie.comRelated Reading: Cancer patients want more info on treatment downside CT radiation increases risk of thyroid cancer, leukemia ASTRO: Radiation can nix side effects of T-cell therapy ASTRO: AI predicts side effects from radiation therapy Routine PET field-of-view enough for pediatric lymphoma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 10, 2019 Category: Radiology Source Type: news

ASTRO issues new guideline on radiation therapy for basal, squamous cell skin cancers
(American Society for Radiation Oncology) A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy to treat patients diagnosed with the most common types of skin cancers. The guideline details when radiation treatments are appropriate as stand-alone therapy or following surgery for basal and cutaneous squamous cell carcinomas (BCC, cSCC), and it suggests dosing and fractionation for these treatments. ASTRO's first guideline for skin cancer published in Practical Radiation Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2019 Category: Cancer & Oncology Source Type: news

Giving common antibiotic before radiation may help body fight cancer
(University of Pennsylvania School of Medicine) The antibiotic vancomycin alters the gut microbiome in a way that can help prime the immune system to more effectively attack tumor cells after radiation therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 9, 2019 Category: Cancer & Oncology Source Type: news

Medtech in a Minute: Dexcom & #039;s Snafu, a VR Surgical Robot, and More
Dexcom Learns a Valuable Lesson  A major server outage rattled Dexcom customers – particularly parents of diabetic children – over the U.S. Thanksgiving holiday weekend. But most were not as mad about the technology glitch as they were about the company's lack of communication about the issue. Dexcom has since fixed the problem and promised to communicate better with customers going forward.   Vicarious Surgical Scores Breakthrough Designation for Surgical Robot Vicarious Surgical is now the first to receive a breakthrough device designatio...
Source: MDDI - December 7, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Brendon M. Stiles, MD, Discusses Low-Dose Radiation Therapy Along with Immunotherapy
The thoracic surgeon from NewYork-Presbyterian Hospital discusses a trial at the institution in which they give low-dose radiation therapy along with immunotherapy at the Annual New York Lung Cancers Symposium ®. (Source: CancerNetwork)
Source: CancerNetwork - December 6, 2019 Category: Cancer & Oncology Authors: Brendon M. Stiles, MD Source Type: news

ViewRay Investors Favor Collaborations with Elekta and Medtronic
ViewRay just announced that it has signed a non-binding memorandum of understanding with both Elekta and Medtronic. Elekta has committed to invest capital for up to a 9.9% minority interest in ViewRay, and Medtronic has agreed to invest in a minority interest in the company. The investments from Elekta and Medtronic are conditioned upon the consummation of an equity capital raise of at least $75 million. ViewRay's largest shareholder, Fosun International Limited, has also committed capital up to an amount that would enable it to maintain its current beneficial ownership percentage in ViewRay. ViewRa...
Source: MDDI - December 2, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Imaging Source Type: news

Latest Mesothelioma Clinical Trial Opens at Memorial Sloan Kettering
Memorial Sloan Kettering Cancer Center in New York City has opened its latest clinical trial for patients with pleural mesothelioma, studying the effectiveness of an immunotherapy and chemotherapy combination prior to aggressive surgery. The novel feasibility study will determine if the use of Opdivo (nivolumab) with Alimta (pemetrexed) and either cisplatin or carboplatin — without delaying scheduled surgery — can significantly extend patient survival time. The hope is to duplicate earlier effectiveness of that same combination with other cancers. “It has been tried with promising results,” Memorial...
Source: Asbestos and Mesothelioma News - November 27, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Cancer Patients Need More Info on Side Effects of Radiation Tx
WEDNESDAY, Nov. 27, 2019 -- Although most cancer patients do not experience anticipated potential adverse effects of radiation therapy, more than one-third have adverse effects that they wish they had known more about, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 27, 2019 Category: Pharmaceuticals Source Type: news

Prostate cancer: radiation therapy effective in patients with no further treatment options
(Saarland University) Prostate cancer accounts for 26 percent of male cancer cases diagnosed in Germany. Scientists and doctors at Saarland University Hospital recently conducted a clinical trial in which they established the effectiveness of a therapeutic method that is very successful in controlling late-stage prostate tumours and their metastases without causing serious side effects. The pilot study has been published in the highly respected medical journal European Journal of Nuclear Medicine and Molecular Imaging. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 25, 2019 Category: Cancer & Oncology Source Type: news

Cancer patients want more info on treatment downside
One in three adults wish they had known more about side effects before beginning...Read more on AuntMinnie.comRelated Reading: Black women still at higher risk of breast cancer death ASTRO: Radiation can nix side effects of T-cell therapy ASTRO: AI predicts side effects from radiation therapy How does chemo during pregnancy affect child development? Advanced imaging offers insight into targeted therapies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 21, 2019 Category: Radiology Source Type: news

St. Louis-born Galera Therapeutics goes public with $60M IPO
Galera Therapeutics, a Pennsylvania-based biotechnology startup that has its research and development segment in St. Louis, has raised $60 million in an initial public offering. The company, which is developing treatments to reduce the harmful effect of radiation therapy, raised the $60 million by selling 5 million shares of its common stock at $12 per share per share. In documents filed with the Securities and Exchange Commission last week, Galera said it expected to sel l its shares at between… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 7, 2019 Category: Biotechnology Authors: John George Source Type: news

Galera Therapeutics goes public with $60 million IPO
Galera Therapeutics on Thursday became the second Philadelphia-area life sciences company to go public in the last two weeks. The Malvern company, developing treatments to reduce the harmful effect of radiation therapy, raised $60 million by selling 5 million shares of its common stock at $12 per share per share. In documents filed with the Securities and Exchange Commission last week, Galera said it expected to sell its shares at between $14 and $16 per share. The stock was trading at $12.70… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 7, 2019 Category: Pharmaceuticals Authors: John George Source Type: news